Yorktown Management & Research Company’s Veracyte VCYT Stock Holding History

Yorktown Management & Research Company’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$455K	Buy	+7,750	New	+$325K	0.28%	135
2025 Q2	–	Sell	-8,900	Closed	-$264K	–	242
2025 Q1	$264K	Buy	+8,900	New	+$339K	0.29%	170

Other funds holding VCYT

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Yorktown Management & Research Company's VCYT Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Veracyte (VCYT) in Q2 2026: 7,750 shares worth $455K. The stake represents 0.28% of the portfolio and ranks #135 among its holdings. This is a return to the name: Yorktown Management & Research Company previously reported a position in VCYT as recently as Q1 2025.

Yorktown Management & Research Company first reported a position in VCYT in Q1 2025 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

Yorktown Management & Research Company held 7,750 shares of Veracyte worth $455K as of Q2 2026.
Veracyte was a new Yorktown Management & Research Company position in Q2 2026.
Veracyte made up 0.28% of Yorktown Management & Research Company's portfolio in Q2 2026, its #135 holding.
Yorktown Management & Research Company first reported a position in Veracyte in Q1 2025 and has held it in 2 quarters since.
56 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.